Century Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	51.05	61.85	58.44	47.32	84.27	56.45
Short-Term Investments	83.76	55.26	130.85	125.41	231.23	166.43
Cash & Short-Term Investments	134.8	117.11	189.29	172.74	315.5	222.88
Cash Growth	-18.36%	-38.13%	9.58%	-45.25%	41.56%	194.22%
Other Current Assets	4.24	3.66	4.76	4.26	4.22	5.28
Total Current Assets	139.04	120.77	194.05	176.99	319.72	228.15
Net Property, Plant & Equipment	68.58	66.17	90.85	92.08	111.73	69.82
Other Intangible Assets	34.2	34.2	34.2	-	-	-
Long-Term Investments	82.17	-	30.82	89.1	51.85	135.91
Other Long-Term Assets	2.57	2.57	3.3	2.52	3.24	3.49
Total Assets	326.55	223.7	353.22	360.69	486.54	437.38
Accounts Payable	3.15	4.77	3.08	2.74	5.45	7.6
Accrued Expenses	8.48	11.68	17.46	10.15	9.84	6.04
Current Portion of Long-Term Debt	-	-	-	-	6.5	1.04
Unearned Revenue	-	-	109.16	4.37	7.15	0
Other Current Liabilities	1.94	3.78	0.08	0.58	0.87	0.98
Total Current Liabilities	13.57	20.23	129.78	17.85	29.82	15.66
Long-Term Debt	-	-	-	-	3.74	8.9
Long-Term Leases	43.94	40.24	48.96	46.66	38.7	14.56
Other Long-Term Liabilities	4.3	4.3	13.11	111.44	111.55	2.02
Total Long-Term Liabilities	48.24	44.54	62.07	158.1	153.99	25.48
Total Liabilities	61.81	64.77	191.85	175.94	183.81	41.14
Common Stock	0.02	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	1,079	950.81	943.37	840.41	824.29	785.05
Accumulated Other Comprehensive Income	-0.59	0.03	0.32	0.11	-2.46	-0.65
Retained Earnings	-813.56	-791.92	-782.34	-655.77	-519.1	-388.17
Shareholders' Equity	264.74	158.94	161.36	184.75	302.74	396.24
Total Liabilities & Equity	326.55	223.7	353.22	360.69	486.54	437.38
Total Debt	43.94	40.24	48.96	46.66	48.94	24.5
Net Cash (Debt)	90.86	76.87	140.33	126.08	266.56	198.38
Net Cash Growth	18.20%	-45.22%	11.30%	-52.70%	34.37%	264.41%
Net Cash Per Share	0.80	0.89	1.78	2.13	4.62	6.12
Book Value	264.74	158.94	161.36	184.75	302.74	396.24
Book Value Per Share	2.34	1.84	2.05	3.11	5.24	12.23
Tangible Book Value	230.54	124.74	127.16	184.75	302.74	396.24
Tangible Book Value Per Share	2.03	1.44	1.62	3.11	5.24	12.23

Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q